| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Durso Timothy August | Chief Technical Officer | C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN | /s/ Michael Greco, Attorney-in-Fact | 03 Feb 2026 | 0002107508 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MANE | Common Stock | 116,717 | 03 Feb 2026 | Direct | ||||||
| holding | MANE | Common Stock | 116,717 | 03 Feb 2026 | By Durso Family Trust | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MANE | Series A Convertible Preferred Stock | 03 Feb 2026 | Common Stock | 1,473 | Direct | F2 | |||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 3,542 | $12.19 | Direct | F3 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 84,504 | $12.19 | Direct | F3 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 3,452 | $12.19 | Direct | F3 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 5,343 | $12.19 | Direct | F3 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 9,864 | $12.19 | Direct | F4 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 5,035 | $12.19 | Direct | F4 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 89,699 | $12.19 | Direct | F5 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 356,689 | $12.79 | Direct | F6 | ||||||
| holding | MANE | Stock Option (Right to Buy) | 03 Feb 2026 | Common Stock | 121,992 | $12.79 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F2 | Each share of Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis and has no expiration date. The Series A Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering. |
| F3 | This option is fully vested and exercisable as of the date hereof. |
| F4 | The option is vested as to 33% of the underlying shares of Common Stock as of January 1, 2025, the first anniversary of the vesting commencement date, and vests as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service. |
| F5 | This option had a vesting start date of November 25, 2024 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date, subject to continued service. |
| F6 | This option had a vesting start date of October 14, 2025 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date, subject to continued service. |
| F7 | This option shall be fully vested and exercisable upon the certification by the Issuer's board of directors (or compensation committee thereof) that the Issuer has achieved a market capitalization of $680.0 million prior to December 31, 2026, subject to the reporting person's continued service. Market capitalization will be measured as the trading price per share of the Issuer's Common Stock on its principal market national stock exchange multiplied by the number of the Issuer's shares of Common Stock issued and outstanding. |
Exhibit List: Exhibit 24 - Power of Attorney